Title: Lanthanum carbonate reduces urine phosphorus excretion: evidence of high-capacity phosphate binding.
Journal: Renal failure 20121201
Title: Npt2b deletion attenuates hyperphosphatemia associated with CKD.
Journal: Journal of the American Society of Nephrology : JASN 20120928
Title: Enantioselective hydrolysis of epichlorohydrin using whole Aspergillus niger ZJB-09173 cells in organic solvents.
Journal: Journal of biosciences 20120901
Title: Dietary phosphate modifies lifespan in Drosophila.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120901
Title: Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20120901
Title: Spontaneous carbonate formation in an amorphous, amine-rich, polymeric drug substance: sevelamer HCl product quality.
Journal: Journal of pharmaceutical sciences 20120801
Title: Phosphate binders in CKD: bad news or good news?
Journal: Journal of the American Society of Nephrology : JASN 20120801
Title: Effects of phosphate binders in moderate CKD.
Journal: Journal of the American Society of Nephrology : JASN 20120801
Title: Case of proximal calciphylaxis with protein S deficiency, successfully treated with multimodality therapy.
Journal: The Journal of dermatology 20120701
Title: Enhancement and restriction of chain motion in polymer networks.
Journal: International journal of pharmaceutics 20120701
Title: Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study.
Journal: Clinical nephrology 20120701
Title: [Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD].
Journal: Clinical calcium 20120701
Title: Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20120601
Title: Effect of gastric acid suppression with pantoprazole on the efficacy of sevelamer hydrochloride as a phosphate binder in haemodialysis patients: a pilot study.
Journal: Nephrology (Carlton, Vic.) 20120501
Title: Non-systemic drugs: a critical review.
Journal: Current pharmaceutical design 20120401
Title: Potential influence of sevelamer hydrochloride on responsiveness to erythropoiesis-stimulating agents in haemodialysis patients.
Journal: Nephrology (Carlton, Vic.) 20120301
Title: Mortality in kidney disease patients treated with phosphate binders: a randomized study.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20120301
Title: Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120201
Title: Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20120201
Title: Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20120201
Title: Directed evolution strategies for enantiocomplementary haloalkane dehalogenases: from chemical waste to enantiopure building blocks.
Journal: Chembiochem : a European journal of chemical biology 20120102
Title: Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20120101
Title: Effects of phosphonoformic acid and renagel on renal type IIa sodium-dependent phosphate cotransporter mRNA expression in hyperphosphatemia rats.
Journal: Renal failure 20120101
Title: Treatment of gabapentin-induced myoclonus with continuous renal replacement therapy.
Journal: Indian journal of nephrology 20120101
Title: Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2.
Journal: PloS one 20120101
Title: Roles of major facilitator superfamily transporters in phosphate response in Drosophila.
Journal: PloS one 20120101
Title: Lanthanum carbonate: a postmarketing observational study of efficacy and safety.
Journal: Journal of nephrology 20120101
Title: Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects.
Journal: Nephron. Clinical practice 20120101
Title: Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients.
Journal: PloS one 20120101
Title: Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
Journal: International journal of biological sciences 20120101
Title: Liver Transplantation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria.
Journal: Case reports in gastroenterology 20120101
Title: Left ventricular diastolic dysfunction in dialysis patients assessed by novel speckle tracking strain rate analysis: prevalence and determinants.
Journal: International journal of nephrology 20120101
Title: Phosphorus and nutrition in chronic kidney disease.
Journal: International journal of nephrology 20120101
Title: Assessment of phosphate binding by sevelamer carbonate powder for oral suspension mixed in foods.
Journal: Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20120101
Title: Recurrent hyperphosphatemic tumoural calcinosis.
Journal: BMJ case reports 20120101
Title: Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20111201
Title: Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
Journal: Artificial organs 20111201
Title: Multi-intervention management of calciphylaxis: a report of 7 cases.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20111201
Title: Pharmacotherapy of chronic kidney disease and mineral bone disorder.
Journal: Expert opinion on pharmacotherapy 20111201
Title: CKD-mineral and bone disorder: core curriculum 2011.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20111201
Title: C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on long-term hemodialysis.
Journal: Clinical nephrology 20111201
Title: Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20111201
Title: Impact of non-traditional phosphate binders and cinacalcet on haemodialysis patient biochemistry, pill burden and cost.
Journal: Nephrology (Carlton, Vic.) 20111101
Title: The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20111101
Title: Efficacy and safety of SBR759, a novel calcium-free, iron(III)-based phosphate binder, in Asian patients undergoing hemodialysis: A 12-week, randomized, open-label, dose-titration study versus sevelamer hydrochloride.
Journal: Nephrology (Carlton, Vic.) 20111101
Title: Does concomitant administration of sevelamer hydrochloride and lanthanum carbonate modify the control of phosphatemia?
Journal: European review for medical and pharmacological sciences 20111101
Title: A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism.
Journal: Clinical nephrology 20111001
Title: Effectiveness and cost-efficacy of phosphate binders in hemodialysis.
Journal: Annals of nutrition & metabolism 20111001
Title: Calcium carbonate, but not sevelamer, is associated with better outcomes in hemodialysis patients: results from the French ARNOS study.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20111001
Title: Pharmacology, efficacy and safety of oral phosphate binders.
Journal: Nature reviews. Nephrology 20110906
Title: Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20110901
Title: Vascular calcification in chronic kidney disease: mechanisms and clinical implications.
Journal: Iranian journal of kidney diseases 20110901
Title: Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing hemodialysis.
Journal: The Korean journal of internal medicine 20110901
Title: Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints.
Journal: Heart (British Cardiac Society) 20110815
Title: A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum.
Journal: Journal of the American Academy of Dermatology 20110801
Title: Diffuse uremic tumoral calcinosis in a patient on long-term hemodialysis.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20110801
Title: Biomechanical properties of bones from rats treated with sevelamer.
Journal: Collegium antropologicum 20110601
Title: Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20110501
Title: The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110501
Title: Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20110501
Title: Mineral metabolism management in Canadian peritoneal dialysis patients.
Journal: Clinical nephrology 20110501
Title: Efficient total synthesis of (+)-dihydropinidine, (-)-epidihydropinidine, and (-)-pinidinone.
Journal: Journal of natural products 20110425
Title: Cardiovascular outcome in asymptomatic hemodialysis patients submitted to aggressive medical therapy: results of a four-year follow-up.
Journal: Minerva cardioangiologica 20110401
Title: Is combined calcium/magnesium phosphate binder really noninferior to sevelamer hydrochloride?
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110401
Title: Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?
Journal: Kidney international. Supplement 20110401
Title: Uremic toxins and oral adsorbents.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20110401
Title: Sevelamer use and incidence of peritonitis in peritoneal dialysis.
Journal: Wiener klinische Wochenschrift 20110401
Title: Mineral metabolism: Sevelamer slows calcification and reduces levels of AGEs.
Journal: Nature reviews. Nephrology 20110401
Title: Does the choice of phosphate binder affect trace element levels in chronic kidney disease patients treated by regular haemodialysis?
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110301
Title: Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20110301
Title: Pharmacology of the phosphate binder, lanthanum carbonate.
Journal: Renal failure 20110301
Title: Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.
Journal: The Cochrane database of systematic reviews 20110216
Title: Sevelamer prescriptions after reporting of the Dialysis Clinical Outcomes Revisited (DCOR) trial findings: An analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20110201
Title: Lanthanum carbonate versus sevelamer hydrochloride: improvement of metabolic acidosis and hyperkalemia in hemodialysis patients.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20110201
Title: Development and validation of rapid ion-chromatographic method with conductivity detection for trace level determination of allylamine in sevelamer drug substances.
Journal: Journal of pharmaceutical and biomedical analysis 20110105
Title: Consequences and therapy of the metabolic acidosis of chronic kidney disease.
Journal: Pediatric nephrology (Berlin, Germany) 20110101
Title: Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110101
Title: Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
Journal: Nephron. Clinical practice 20110101
Title: Effect of sevelamer hydrochloride exposure on carotid intima media thickness in hemodialysis patients.
Journal: Nephron. Clinical practice 20110101
Title: Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.
Journal: Kidney international 20110101
Title: Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20110101
Title: Phosphate binder is not phosphate binder! Sevelamer may be different!
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110101
Title: Reduction of hyperphosphatemia is related with the reduction of C-reactive protein in dialysis patients. Study in sevelamer-resistant dialysis patients treated with chitosan chewing gum as salivary phosphate binder.
Journal: Renal failure 20110101
Title: [Chronic kidney disease and atherosclerosis].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20110101
Title: Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.
Journal: Wiener klinische Wochenschrift 20110101
Title: Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial.
Journal: Trials 20110101
Title: Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: a randomized, open-label, parallel-group study.
Journal: Clinical drug investigation 20110101
Title: Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.
Journal: International journal of nephrology 20110101
Title: New-onset headache in an elderly man with uremia that improved only after correction of hyperphosphatemia ('uremic headache'): a case report.
Journal: Journal of medical case reports 20110101
Title: Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis.
Journal: BMJ (Clinical research ed.) 20110101
Title: Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?
Journal: BMC nephrology 20110101
Title: The Effect of Paricalcitol on Vascular Calcification and Cardiovascular Disease in Uremia: Beyond PTH Control.
Journal: International journal of nephrology 20110101
Title: Dyslipidemia associated with chronic kidney disease.
Journal: The open cardiovascular medicine journal 20110101
Title: Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification.
Journal: International journal of nephrology 20110101
Title: Phosphate Metabolism in CKD Stages 3-5: Dietary and Pharmacological Control.
Journal: International journal of nephrology 20110101
Title: Pharmacological management of cardiorenal syndromes.
Journal: International journal of nephrology 20110101
Title: Arterial stiffness in chronic kidney disease: the usefulness of a marker of vascular damage.
Journal: International journal of nephrology 20110101
Title: Use of percutaneous ethanol injection therapy for recurrent secondary hyperparathyroidism after subtotal parathyroidectomy.
Journal: International journal of nephrology 20110101
Title: Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients.
Journal: International journal of nephrology 20110101
Title: Calcific uremic arteriolopathy in peritoneal dialysis populations.
Journal: International journal of nephrology 20110101
Title: [Effect of non-calcium-based phosphate binders on vascular calcifications in patients on hemodialysis: clinical experience and hypotheses].
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20110101
Title: [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960) 20110101
Title: Vascular and valvular calcification in chronic peritoneal dialysis patients.
Journal: International journal of nephrology 20110101
Title: Phosphate binders: Sevelamer in the prevention and treatment of hyperphosphataemia in chronic renal failure.
Journal: Hippokratia 20110101
Title: Renal artery stenosis in kidney transplants: assessment of the risk factors.
Journal: Vascular health and risk management 20110101
Title: Regression of vascular calcification in a patient treated with cinacalcet: a case report.
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101
Title: Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study.
Journal: BMC nephrology 20110101
Title: Carotid artery calcification at the initiation of hemodialysis is a risk factor for cardiovascular events in patients with end-stage renal disease: a cohort study.
Journal: BMC nephrology 20110101
Title: Lower gastrointestinal bleeding in chronic hemodialysis patients.
Journal: International journal of nephrology 20110101
Title: Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis.
Journal: Indian journal of nephrology 20110101
Title: Levothyroxine and sevelamer: listen to the patient.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101
Title: Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemia.
Journal: Health economics review 20110101
Title: Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4.
Journal: International urology and nephrology 20101201
Title: Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20101201
Title: Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20101101
Title: Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III - V).
Journal: Expert opinion on pharmacotherapy 20101101
Title: [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Journal: Clinical calcium 20101101
Title: FGF-23: More than a regulator of renal phosphate handling?
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101001
Title: 'Real-World' use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study.
Journal: Clinical nephrology 20100901
Title: Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi 20100901
Title: Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100801
Title: Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.
Journal: Leukemia research 20100701
Title: Lanthanum carbonate is an effective hypophosphatemic agent for hemodialysis patients intolerant of other phosphate binders.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20100701
Title: Impact of phosphate binder type on coronary artery calcification in hemodialysis patients.
Journal: Clinical nephrology 20100701
Title: Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
Journal: Pharmacotherapy 20100701
Title: [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality].
Journal: Clinical calcium 20100701
Title: [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Parathyroid interventions: final one piece in the management of uremic SHPT patients].
Journal: Clinical calcium 20100701
Title: Homocysteine and folic acid levels in hemodialysis patients treated with sevelamer hydrochloride.
Journal: Clinical nephrology 20100601
Title: Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20100601
Title: Sevelamer carbonate. No better than sevelamer hydrochloride.
Journal: Prescrire international 20100601
Title: Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20100501
Title: Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients.
Journal: American journal of nephrology 20100501
Title: [Secondary osteoporosis UPDATE. Therapy for bone-mineral disease in CKD-5D patients].
Journal: Clinical calcium 20100501
Title: Is excess calcium harmful to health?
Journal: Nutrients 20100501
Title: Oral phosphate binders in patients with kidney failure.
Journal: The New England journal of medicine 20100408
Title: Sevelamer 'carbonate': what's in a name?
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100401
Title: Novel markers of left ventricular hypertrophy in uremia.
Journal: American journal of nephrology 20100401
Title: New therapies: calcimimetics, phosphate binders and vitamin D receptor activators.
Journal: Pediatric nephrology (Berlin, Germany) 20100401
Title: [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].
Journal: Nephrologie & therapeutique 20100401
Title: Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20100401
Title: Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia?
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20100401
Title: Report of an unusual case with severe fecal impaction responding to medication therapy.
Journal: Journal of neurogastroenterology and motility 20100401
Title: Can we reduce the cardiovascular risk in peritoneal dialysis patients?
Journal: Indian journal of nephrology 20100401
Title: Phosphate binders in CKD: chalking out the differences.
Journal: Pediatric nephrology (Berlin, Germany) 20100301
Title: Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?
Journal: Collegium antropologicum 20100301
Title: Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients.
Journal: Pediatric nephrology (Berlin, Germany) 20100201
Title: Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?
Journal: Clinical journal of the American Society of Nephrology : CJASN 20100201
Title: A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20100201
Title: Interventions for bone disease in children with chronic kidney disease.
Journal: The Cochrane database of systematic reviews 20100120
Title: Sevelamer carbonate.
Journal: The Annals of pharmacotherapy 20100101
Title: Metal ion and vitamin adsorption profiles of phosphate binder ion-exchange resins.
Journal: Clinical nephrology 20100101
Title: Ten-year experience with sevelamer and calcium salts as phosphate binders.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20100101
Title: The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20100101
Title: Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study.
Journal: Journal of nephrology 20100101
Title: Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?
Journal: Journal of nephrology 20100101
Title: Sevelamer decreases systemic inflammation in parallel to a reduction in endotoxemia.
Journal: Blood purification 20100101
Title: Meta-analysis comparing sevelamer and calcium-based phosphate binders on cardiovascular calcification in hemodialysis patients.
Journal: Nephron. Clinical practice 20100101
Title: A comparative study of 2 new phosphate binders (sevelamer and lanthanum carbonate) in routine clinical practice.
Journal: Journal of nephrology 20100101
Title: Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients.
Journal: BMC nephrology 20100101
Title: [Phosphorus binders: preferences of patients on haemodialysis and its impact on treatment compliance and phosphorus control].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20100101
Title: Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.
Journal: Gene regulation and systems biology 20100101
Title: [Analysis of the efficacy and factors influencing the response of secondary hyperparathyroidism patients on hemodialysis to cinacalcet].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20100101
Title: Failed Switching off in the MIBI-Parathyroid Scintigraphy in a Dialyzed Patient with Secondary Hyperparathyroidism Responsive to Cinacalcet Therapy.
Journal: International journal of endocrinology 20100101
Title: Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.
Journal: BMJ (Clinical research ed.) 20100101
Title: Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.
Journal: Oxidative medicine and cellular longevity 20100101
Title: Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia.
Journal: Blood purification 20100101
Title: The control of hyperphosphatemia in renal failure: between vascular calcification and inflammation.
Journal: Blood purification 20100101
Title: Determination of residual epichlorohydrin in sevelamer hydrochloride by static headspace gas chromatography with flame ionization detection.
Journal: Scientia pharmaceutica 20100101
Title: Inflammation as a target for improving health in chronic kidney disease.
Journal: F1000 medicine reports 20100101
Title: End-stage renal disease.
Journal: BMJ clinical evidence 20100101
Title: New and improved strategies for the treatment of gout.
Journal: International journal of nephrology and renovascular disease 20100101
Title: Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20091201
Title: A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20091201
Title: Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20091201
Title: Uremic toxins originating from colonic microbial metabolism.
Journal: Kidney international. Supplement 20091201
Title: Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism.
Journal: Kidney international. Supplement 20091201
Title: Sevelamer and the bone-vascular axis in chronic kidney disease: bone turnover, inflammation, and calcification regulation.
Journal: Kidney international. Supplement 20091201
Title: Lanthanum carbonate: a review of its use in lowering serum phosphate in patients with end-stage renal disease.
Journal: Drugs 20091112
Title: The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20091001
Title: Sevelamer versus calcium-based phosphate binders in chronic kidney disease: what should we conclude from the evidence to date?
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20091001
Title: Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20091001
Title: Treating mineral metabolism disorders in patients undergoing long hemodialysis: a search for an optimal strategy.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20091001
Title: Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study.
Journal: Clinical nephrology 20091001
Title: A bitter pill to swallow.
Journal: Clinical nephrology 20091001
Title: Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis.
Journal: Indian journal of nephrology 20091001
Title: Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090901
Title: Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20090901
Title: Improvement in secondary hyperparathyroidism due to drug adherence monitoring in dialysis patients.
Journal: Clinical nephrology 20090901
Title: Sevelamer reduces the efficacy of many other drugs.
Journal: Prescrire international 20090801
Title: Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols.
Journal: Pediatric nephrology (Berlin, Germany) 20090701
Title: Predictors of anemia in patients on hemodialysis.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20090701
Title: Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20090701
Title: Calciphylaxis in chronic renal failure: An approach to risk factors.
Journal: Indian journal of nephrology 20090701
Title: [Clinical aspect of recent progress in phosphate metabolism. Phosphate retension, a powerful risk factor for mortality in chronic kidney disease (CKD)].
Journal: Clinical calcium 20090601
Title: [Clinical aspect of recent progress in phosphate metabolism. Management of hyperphosphagtemia].
Journal: Clinical calcium 20090601
Title: Oral phosphate binders.
Journal: Kidney international 20090501
Title: Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications.
Journal: Pharmacotherapy 20090501
Title: Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
Journal: British journal of pharmacology 20090401
Title: [Chronic kidney disease (CKD) and bone. Control of CKD-MBD from the viewpoint of the medical cost].
Journal: Clinical calcium 20090401
Title: [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].
Journal: Clinical calcium 20090401
Title: [Chronic kidney disease (CKD) and bone. Vascular calcification in CKD].
Journal: Clinical calcium 20090401
Title: [The use of sevelamer in the treatment of resistant hyperphosphataemia in children with chronic renal disease].
Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20090401
Title: [Cinacalcet in the treatment of secondary hyperparathyreoidism in a child with chronic kidney disease--case report].
Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20090401
Title: Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials.
Journal: Lancet (London, England) 20090321
Title: Long-term outcome of chronic dialysis in children.
Journal: Pediatric nephrology (Berlin, Germany) 20090301
Title: Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090301
Title: Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090301
Title: The use of phosphate binders: data from contributors to the European Practice Database.
Journal: Journal of renal care 20090301
Title: Update on the treatment of chronic kidney disease-mineral and bone disorder.
Journal: Journal of renal care 20090301
Title: Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Journal: Journal of renal care 20090301
Title: [Management of phosphate in chronic kidney disease--Chemistry and history of phosphate binder].
Journal: Clinical calcium 20090201
Title: [Management of hyperphosphatemia ; phosphate-binder].
Journal: Clinical calcium 20090201
Title: [Management of phosphate in chronic kidney disease--Clinical trials of lanthanum carbonate].
Journal: Clinical calcium 20090201
Title: [Use of phosphate binder in predialysis patients].
Journal: Clinical calcium 20090201
Title: [Novel phosphate binders under development].
Journal: Clinical calcium 20090201
Title: [To facilitate the compliance of phosphate binder for the control of hyperphosphatemia in chronic kidney disease patients].
Journal: Clinical calcium 20090201
Title: Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism (SHPT) in hemodialysis patients.
Journal: Clinical nephrology 20090201
Title: The control of hyperphosphatemia in chronic kidney disease: which phosphate binder?
Journal: The International journal of artificial organs 20090201
Title: Effect of sevelamer hydrochloride on bone in experimental uremic rats.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20090201
Title: Prevention and management of hyperphosphatemia with sevelamer in Canada: health and economic consequences.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101
Title: Diaminobutane (DAB) dendrimers are potent binders of oral phosphate.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090101
Title: Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090101
Title: Phosphate binders in chronic kidney disease and end-stage renal disease: a patient-centered approach.
Journal: Seminars in dialysis 20090101
Title: Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients on sevelamer hydrochloride: which dialysate calcium concentration to use?
Journal: Blood purification 20090101
Title: Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.
Journal: American journal of nephrology 20090101
Title: Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
Journal: Hormone research 20090101
Title: Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients.
Journal: Journal of Korean medical science 20090101
Title: [Treating distal calciphylaxis with therapy associated with sevelamer and bisphosphonates].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20090101
Title: Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients.
Journal: Internal medicine (Tokyo, Japan) 20090101
Title: [Prescription of phosphorus binders and calcitriol for chronic hemodialysis patients].
Journal: Revista da Associacao Medica Brasileira (1992) 20090101
Title: [Multiple peritrochanteric and pubic calcifications in a young woman on hemodialysis with severe renal osteodystrophy successfully treated with sevelamer+cinacalcet+paracalcitol combination therapy].
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20090101
Title: A 44 year-old lady with chronic renal disease and intractable ulcers: a case report.
Journal: International archives of medicine 20090101
Title: Strategies to manage low-bone turnover.
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20090101
Title: Cardiovascular disease in patients with chronic kidney disease.
Journal: Vascular health and risk management 20090101
Title: African American female with renal failure presenting with skin lesions: a case report.
Journal: Cases journal 20090101
Title: A 60-year-old man with chronic renal failure and a costal mass: a case report and review of the literature.
Journal: Journal of medical case reports 20090101
Title: Vascular calcification and QT interval in incident hemodialysis patients.
Journal: Journal of nephrology 20090101
Title: Lanthanum associated abnormal liver function tests in two patients on dialysis: a case report.
Journal: Journal of medical case reports 20090101
Title: Effectiveness and cost-efficiency of phosphate binders in hemodialysis.
Journal: GMS health technology assessment 20090101
Title: Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate.
Journal: International journal of nephrology and renovascular disease 20090101
Title: Abdominal aortic calcification in dialysis patients: results of the CORD study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081201
Title: Sevelamer restores bone volume and improves bone microarchitecture and strength in aged ovariectomized rats.
Journal: Endocrinology 20081201
Title: The CARE-2 study results: setting the record straight.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081201
Title: Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20081201
Title: Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data.
Journal: Kidney international. Supplement 20081201
Title: A review article: sevelamer hydrochloride and metabolic acidosis in dialysis patients.
Journal: Cardiovascular & hematological disorders drug targets 20081201
Title: Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081101
Title: Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20081101
Title: Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20081101
Title: Binder wars.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20081101
Title: Effects of treatment of renal osteodystrophy on bone histology.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20081101
Title: New strategies in treatment of mineral and bone disorders and associated cardiovascular disease in patients with chronic kidney disease.
Journal: Recent patents on cardiovascular drug discovery 20081101
Title: Overcoming obstacles for adherence to phosphate binding medication in dialysis patients: a qualitative study.
Journal: Pharmacy world & science : PWS 20081001
Title: Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081001
Title: Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20081001
Title: Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate.
Journal: Therapeutics and clinical risk management 20081001
Title: Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080901
Title: Vitamin D deficiency and associated factors in hemodialysis patients.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20080901
Title: Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging.
Journal: The international journal of cardiovascular imaging 20080801
Title: Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis.
Journal: Therapeutics and clinical risk management 20080801
Title: Sevelamer hydrochloride: a novel treatment of hyperphosphatemia associated with tumor lysis syndrome in children.
Journal: Pediatric blood & cancer 20080701
Title: Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20080701
Title: Time-dependent effect of sevelamerHCl on the cardiovascular system.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080601
Title: Sevelamer.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080601
Title: A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20080601
Title: Buffering effects of calcium carbonate as clarified by sevelamer hydrochloride monotherapy.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20080601
Title: Sevelamer: constipation and occlusion. Complications, sometimes fatal.
Journal: Prescrire international 20080601
Title: Therapeutic strategies to slow chronic kidney disease progression.
Journal: Pediatric nephrology (Berlin, Germany) 20080501
Title: Lack of mortality benefit with sevelamer.
Journal: Kidney international 20080501
Title: Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease.
Journal: Reviews on recent clinical trials 20080501
Title: Lower gastrointestinal bleeding: association with Sevelamer use.
Journal: World journal of gastroenterology 20080428
Title: Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model.
Journal: Nephrology (Carlton, Vic.) 20080401
Title: Use of sevelamer hydrochloride as an oxalate binder.
Journal: The Journal of urology 20080401
Title: Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20080401
Title: [Treatment of secondary hyperparathyroidism in renal insufficiency: role of calcitriol, sevelamer and cinacalcet].
Journal: Revue medicale suisse 20080305
Title: The effects of conformation and solvation on optical rotation: substituted epoxides.
Journal: Chirality 20080301
Title: Ectopic mineralization of connective tissue in Abcc6-/- mice: effects of dietary modifications and a phosphate binder--a preliminary study.
Journal: Experimental dermatology 20080301
Title: K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients.
Journal: Kidney international 20080301
Title: Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial.
Journal: International urology and nephrology 20080301
Title: Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20080301
Title: A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20080301
Title: Effect of sevelamer on mineral and lipid abnormalities in hemodialysis patients.
Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20080301
Title: Total synthesis of (+)-yatakemycin.
Journal: Chemistry, an Asian journal 20080201
Title: Chronic kidney disease mineral and bone disorder in children.
Journal: Pediatric nephrology (Berlin, Germany) 20080201
Title: Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.
Journal: Journal of the American Society of Nephrology : JASN 20080201
Title: An economic evaluation of sevelamer in patients new to dialysis.
Journal: Current medical research and opinion 20080201
Title: Block randomized trial evidencing lower mortality with sevelamer compared with calcium phosphate binder in incident dialysis patients.
Journal: Kidney international 20080201
Title: Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20080201
Title: A pragmatic recipe for the treatment of hindered rotations in the vibrational averaging of molecular properties.
Journal: Chemphyschem : a European journal of chemical physics and physical chemistry 20080111
Title: Phosphate binders and timing of levothyroxine administration.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080101
Title: Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients.
Journal: American journal of nephrology 20080101
Title: After several years of witchhunting, can calcium-based phosphate binding be released on probation?
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080101
Title: Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20080101
Title: The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Journal: Academic radiology 20080101
Title: Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysis.
Journal: Drugs 20080101
Title: Calciphylaxis of both proximal and distal distribution.
Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20080101
Title: Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20080101
Title: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. No good evidence to promote a general use of sevelamer.
Journal: Kidney international 20080101
Title: [Basic and clinical aspects of calcimimetics. Calcimimetics from the viewpoint of medical cost].
Journal: Clinical calcium 20080101
Title: Efficacy and side effects of sevelamer hydrochloride as sole phosphate binder in peritoneal dialysis patients with severe hyperphosphatemia.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20080101
Title: [Safety and effectiveness of nicotinic acid in the management of patients with chronic renal disease and hyperlipidemia associated to hyperphosphatemia].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101
Title: [Therapeutic options for mineral metabolism disorders in dialysis patients: a case report].
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20080101
Title: Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
Journal: Nephron. Clinical practice 20080101
Title: Preventive measures and new pharmacological approaches of calcium and phosphate disorders.
Journal: Contributions to nephrology 20080101
Title: [Use of the aluminum phosphate-binders in hemodialysis in the ultrapure water era].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101
Title: Endotoxin-binding affinity of sevelamer hydrochloride.
Journal: American journal of nephrology 20080101
Title: Nonphosphate-binding effects of sevelamer--are they of clinical relevance?
Journal: Seminars in dialysis 20080101
Title: Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.
Journal: CANNT journal = Journal ACITN 20080101
Title: Calcium and the saga of the binders: accumulating controversy, or building consensus?
Journal: International urology and nephrology 20080101
Title: [Clinical advances in vascular calcification].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101
Title: [Control of phosphorus and treatment with vitamin D in chronic kidney disease prior to the start of dialysis].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101
Title: [Phosphorus (P) chelant in dialysis: efficacy and cost. Peritoneal dialysis solutions].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101
Title: Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study.
Journal: Nephron. Clinical practice 20080101
Title: Switching from calcium carbonate to sevelamer hydrochloride has suppressive effects on the progression of aortic calcification in hemodialysis patients: assessment using plain chest X-ray films.
Journal: Renal failure 20080101
Title: [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101
Title: [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101
Title: Hemipelvic osteomyelitis in a hemodialysis patient associated with methicillin-resistant Staphylococcus aureus bacteremia.
Journal: International journal of nephrology and renovascular disease 20080101
Title: Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs.
Journal: International journal of nephrology and renovascular disease 20080101
Title: Factors associated with mortality in patients new to haemodialysis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20071201
Title: Chronic acid-base perturbations in hemodialysis patients treated with sevelamer hydrochloride: a two-year follow-up study.
Journal: Artificial organs 20071201
Title: A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate.
Journal: Current medical research and opinion 20071201
Title: Survival in end stage renal disease: calcium carbonate vs. sevelamer.
Journal: Journal of clinical pharmacy and therapeutics 20071201
Title: Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates.
Journal: Journal of the American Academy of Dermatology 20071201
Title: Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20071201
Title: CKD-MBD: impact on management of kidney disease.
Journal: Clinical and experimental nephrology 20071201
Title: A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis.
Journal: Clinical nephrology 20071201
Title: Juice powder concentrate and systemic blood pressure, progression of coronary artery calcium and antioxidant status in hypertensive subjects: a pilot study.
Journal: Evidence-based complementary and alternative medicine : eCAM 20071201
Title: Atherosclerosis and vascular calcification in uraemia - a new experimental model.
Journal: Prilozi 20071201
Title: Study probes best choice of drug to reduce phosphate in patients on dialysis.
Journal: JAMA 20071107
Title: Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Journal: Kidney international 20071101
Title: The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.
Journal: Kidney international 20071101
Title: Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20071101
Title: The details bedevil DCOR.
Journal: Kidney international 20071101
Title: Relative in vitro efficacy of the phosphate binders lanthanum carbonate and sevelamer hydrochloride.
Journal: Journal of pharmaceutical sciences 20071001
Title: Economic evaluation of sevelamer in patients with end-stage renal disease.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20071001
Title: Effect of sevelamer on aortic pulse wave velocity in patients on hemodialysis: a prospective observational study.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20071001
Title: Sevelamer: a promising but unproven drug.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20071001
Title: Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20071001
Title: Calcium and phosphorus control in patients undergoing hemodialysis: from the view-points of activities of daily living.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20071001
Title: Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease.
Journal: Expert opinion on emerging drugs 20070901
Title: Emerging drugs for hyperphosphatemia.
Journal: Expert opinion on emerging drugs 20070901
Title: [A case of the metastatic calcification of trachea, bronchus, and lung].
Journal: Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20070901
Title: Lipoprotein metabolism in chronic renal insufficiency.
Journal: Pediatric nephrology (Berlin, Germany) 20070801
Title: Hyperostosis with hyperphosphatemia and tumoral calcinosis: a case report.
Journal: Pediatric nephrology (Berlin, Germany) 20070801
Title: Transient acid exposure increases sevelamer HCl phosphate binding.
Journal: Journal of pharmaceutical sciences 20070801
Title: New medications which decrease levothyroxine absorption.
Journal: Thyroid : official journal of the American Thyroid Association 20070801
Title: Sevelamer and extension studies.
Journal: Kidney international 20070701
Title: Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070601
Title: Influence of sevelamer on mineral metabolism and hyperparathyroidism in Japanese hemodialysis patients.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20070601
Title: Does Sevelamer reduce mortality by slowing of progression of coronary calcification?
Journal: Kidney international 20070601
Title: [Phosphate binder up to date].
Journal: Clinical calcium 20070501
Title: Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20070401
Title: Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
Journal: Prescrire international 20070401
Title: Hyperphosphatemia in dialysis patients: the therapeutic role of lanthanum carbonate.
Journal: The International journal of artificial organs 20070401
Title: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
Journal: Kidney international 20070301
Title: Control of hyperphosphatemia beyond phosphate.
Journal: Kidney international 20070301
Title: [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
Journal: Clinical calcium 20070301
Title: [Relationship between sevelamer HCl and vascular calcification].
Journal: Clinical calcium 20070301
Title: Vitamin D analogs for secondary hyperparathyroidism: what does the future hold?
Journal: The Journal of steroid biochemistry and molecular biology 20070301
Title: [How to reach and maintain the K/DOQI recommendations for bone and mineral metabolism in patients undergoing haemodialysis: an efficient strategy].
Journal: Nephrologie & therapeutique 20070301
Title: Cost of applying the K/DOQI guidelines for bone metabolism and disease to a cohort of chronic hemodialysis patients.
Journal: Kidney international 20070201
Title: Potential usefulness of sevelamer hydrochloride to improve cardiac outcome in patients with coronary disease and normal renal function.
Journal: Medical hypotheses 20070101
Title: Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy.
Journal: Journal of the American Society of Nephrology : JASN 20070101
Title: Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement.
Journal: International urology and nephrology 20070101
Title: Animal models--what they can tell us about vascular calcification in CKD.
Journal: Seminars in dialysis 20070101
Title: Vascular calcification and disordered mineral metabolism in dialysis patients.
Journal: Seminars in dialysis 20070101
Title: Vascular calcification--a new window on the cardiovascular system: role of agents used to manipulate skeletal integrity.
Journal: Seminars in dialysis 20070101
Title: Final Word: The binders wars 2007-2017: 'The truth is out there somewhere...'.
Journal: Seminars in dialysis 20070101
Title: Causes and consequences of increased arterial stiffness in chronic kidney disease patients.
Journal: Kidney & blood pressure research 20070101
Title: Effect of sevelamer hydrochloride on markers of bone turnover in Japanese dialysis patients with low biointact PTH levels.
Journal: Internal medicine (Tokyo, Japan) 20070101
Title: Sevelamer and other anion-exchange resins in the prevention and treatment of hyperphosphataemia in chronic renal failure.
Journal: Nephron. Physiology 20070101
Title: Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial.
Journal: Trials 20070101
Title: Consequences of the implementation of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease in a population of patients on chronic hemodialysis.
Journal: Journal of nephrology 20070101
Title: [Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20070101
Title: Sevelamer hydrochloride in peritoneal dialysis patients: results of a multicenter cross-sectional study.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20070101
Title: Sevelamer treatment strategy in peritoneal dialysis patients: conventional dose does not make best use of resources.
Journal: Journal of nephrology 20070101
Title: Hypercalcemia after transplant nephrectomy in a hemodialysis patient: a case report.
Journal: Journal of medical case reports 20070101
Title: Synthesis of enantiopure pseudo-L-vinylcyclopropyl nucleosides bearing quaternary carbon as potential anti-herpesvirus agent.
Journal: Nucleosides, nucleotides & nucleic acids 20070101
Title: Clinical consequences and novel therapy of hyperphosphatemia: Lanthanum carbonate for dialysis patients.
Journal: Recent patents on cardiovascular drug discovery 20070101
Title: [K-DOQI guidelines for calcium and phosphorus metabolism in chronic kidney disease: outcomes, compliance and new drugs for treatment].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20070101
Title: End stage renal disease.
Journal: BMJ clinical evidence 20070101
Title: A new era in phosphate binder therapy: what are the options?
Journal: Kidney international. Supplement 20061201
Title: Pleiotropic effects of the non-calcium phosphate binder sevelamer.
Journal: Kidney international. Supplement 20061201
Title: Lanthanum carbonate.
Journal: Drugs of today (Barcelona, Spain : 1998) 20061201
Title: Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
Journal: Journal of molecular graphics & modelling 20061101
Title: Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20061101
Title: The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
Journal: The Journal of clinical endocrinology and metabolism 20061001
Title: Review of dialysate calcium concentration in hemodialysis.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis 20061001
Title: Emerging strategies for lowering serum phosphorous in patients with end-stage renal disease.
Journal: Expert opinion on pharmacotherapy 20061001
Title: The safety of phosphate binders.
Journal: Expert opinion on drug safety 20060901
Title: Results of a randomized crossover study comparing once-daily and thrice-daily sevelamer dosing.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20060901
Title: Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060801
Title: Novel dosage forms and regimens for sevelamer-based phosphate binders.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20060701
Title: The case against calcium-based phosphate binders.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20060701
Title: Calcium-based phosphate binders are appropriate in chronic renal failure.
Journal: Clinical journal of the American Society of Nephrology : CJASN 20060701
Title: Total synthesis of (+)-yatakemycin.
Journal: Journal of the American Chemical Society 20060607
Title: Molecular modeling studies of the binding characteristics of phosphates to sevelamer hydrochloride--assessing a novel technique to reduce phosphates contamination.
Journal: International journal of environmental research and public health 20060601
Title: Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
Journal: Nature clinical practice. Nephrology 20060601
Title: Diarrhea induced by high doses of nicotinamide in dialysis patients.
Journal: Kidney international 20060501
Title: Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.
Journal: Clinical nephrology 20060501
Title: Phosphate binders.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060415
Title: A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20060401
Title: Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Journal: Nephrology (Carlton, Vic.) 20060401
Title: Sevelamer hydrochloride reverses parathyroid gland enlargement via regression of cell hypertrophy but not apoptosis in rats with chronic renal insufficiency.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060301
Title: Sevelamer therapy for pediatric end-stage renal disease.
Journal: Pharmacotherapy 20060301
Title: Effects of sevelamer and calcium on coronary artery calcification in patients new to dialysis: time for better controlled clinical trials.
Journal: Kidney international 20060301
Title: The CARE study and cardiovascular calcification.
Journal: Managed care (Langhorne, Pa.) 20060301
Title: Does sevelamer have greater skeletal benefit than calcium carbonate in children with secondary hyperparathyroidism?
Journal: Nature clinical practice. Nephrology 20060301
Title: Attitude of Physicians towards the Management of Bone Disease in Hemodialysis Patients: A Questionnaire Based Survey.
Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20060301
Title: Phosphate binders.
Journal: The Medical letter on drugs and therapeutics 20060213
Title: Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.
Journal: Pediatric nephrology (Berlin, Germany) 20060201
Title: Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060201
Title: Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
Journal: Kidney international 20060201
Title: Lanthanum carbonate.
Journal: The Annals of pharmacotherapy 20060201
Title: The continuous challenge of cardiovascular and bone and bone disease in uremic patients: clinical consequences of hyperphosphatemia and advanced therapeutic approaches.
Journal: Journal of nephrology 20060101
Title: Lanthanum: a safe phosphate binder.
Journal: Seminars in dialysis 20060101
Title: Sevelamer hydrochloride in peritoneal dialysis patients: ca' canny but ca' awa'.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20060101
Title: Sevelamer hydrochloride versus aluminum hydroxide: effect on serum phosphorus and lipids in CAPD patients.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20060101
Title: Sevelamer worsens metabolic acidosis in hemodialysis patients.
Journal: Journal of nephrology 20060101
Title: Long-term management of sevelamer hydrochloride-induced metabolic acidosis aggravation and hyperkalemia in hemodialysis patients.
Journal: Renal failure 20060101
Title: Minimizing bone abnormalities in children with renal failure.
Journal: Paediatric drugs 20060101
Title: Can discrete event simulation be of use in modelling major depression?
Journal: Cost effectiveness and resource allocation : C/E 20060101
Title: A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
Journal: Renal failure 20060101
Title: A comparative study on the cost of new antibiotics and drugs of other therapeutic categories.
Journal: PloS one 20060101
Title: Phosphate overload accelerates vascular aging in uremic patients.
Journal: Heart international 20060101
Title: Calciphylaxis in pediatric end-stage renal disease.
Journal: Pediatric nephrology (Berlin, Germany) 20051201
Title: Hyperphosphatemia and phosphate binders.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051115
Title: Effect of lipid modification on progression of coronary calcification.
Journal: Journal of the American Society of Nephrology : JASN 20051101
Title: Strategies for improving long-term survival in patients with ESRD.
Journal: Journal of the American Society of Nephrology : JASN 20051101
Title: Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
Journal: Circulation 20051101
Title: Does sevelamer have anti-atherosclerotic properties in maintenance hemodialysis patients?
Journal: Nature clinical practice. Nephrology 20051101
Title: Drug interaction between sevelamer and furosemide.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20051001
Title: Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.
Journal: Kidney international 20051001
Title: Gastric pH, sevelamer hydrochloride and omeprazole.
Journal: Clinical nephrology 20051001
Title: The effect of sevelamer on tacrolimus target levels.
Journal: Transplantation 20050915
Title: [Treatment of adynamic bone disease with the complete replacement from calcium carbonate to sevelamer hydrochloride].
Journal: Clinical calcium 20050901
Title: [Treatment with phosphate binder (sevelamer hydrochloride, calcium carbonate) based on PTH].
Journal: Clinical calcium 20050901
Title: [Defining the role of sevelamer chloride as a therapeutic agent for management of phosphate in patient with hemodialysis].
Journal: Clinical calcium 20050901
Title: [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
Journal: Clinical calcium 20050901
Title: [Clinical analysis of time-course changes in minerals and parathyroid hormone levels during treatment with phosphate binders in hemodialysis patients with secondary hyperparathyroidism].
Journal: Clinical calcium 20050901
Title: [Control of calcium and phosphate in hemodialysis patients].
Journal: Clinical calcium 20050901
Title: [Relationship between serum calcium level and PTH concentration proved with sevelamer hydrochloride].
Journal: Clinical calcium 20050901
Title: [Clinical effect of introduction of sevelamer hydrochloride in patients with hyperphosphatemia undergoing maintenance dialysis].
Journal: Clinical calcium 20050901
Title: [Sevelamer hydrochloride and K/DOQI guidelines].
Journal: Clinical calcium 20050901
Title: [Sevelamer hydrochloride and vitamin D for controlling serum calcium, phosphorus and bone metabolism in patients undergoing hemodialysis].
Journal: Clinical calcium 20050901
Title: [Role of sevelamer hydrochloride in the Coronary Artery Calcification Index].
Journal: Clinical calcium 20050901
Title: [Management of secondary hyperparathyroidism].
Journal: Clinical calcium 20050901
Title: [Present status and problems in vitamin D and sevelamer therapy (discussion)].
Journal: Clinical calcium 20050901
Title: Length of interdialytic interval influences serum calcium and phosphorus concentrations.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050801
Title: Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050801
Title: Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
Journal: Journal of the American Society of Nephrology : JASN 20050801
Title: Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050801
Title: Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050801
Title: Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050801
Title: Management of calcium, phosphorus and bone metabolism in dialysis patients using sevelamer hydrochloride and vitamin D therapy.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050801
Title: Introduction to sevelamer hydrochloride and its clinical effects.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050801
Title: Role of sevelamer hydrochloride in the coronary artery calcification score.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050801
Title: Management of secondary hyperparathyroidism.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050801
Title: Impact of sevelamer hydrochloride and the K/DOQI guidelines.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050801
Title: [Pharmacologic intervention for vascular calcification].
Journal: Clinical calcium 20050701
Title: Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
Journal: Kidney international. Supplement 20050601
Title: Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end-stage renal disease (ESRD).
Journal: Kidney international. Supplement 20050601
Title: End stage renal disease.
Journal: Clinical evidence 20050601
Title: Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050501
Title: Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Journal: American heart journal 20050501
Title: New strategy to attenuate pulse wave velocity in haemodialysis patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050401
Title: Modeling the implications of changes in vascular calcification in patients on hemodialysis.
Journal: Kidney international 20050401
Title: Economic impact of sevelamer in patients with ESRD.
Journal: Kidney international 20050401
Title: Opportunity and cost of sevelamer in dialysis patients.
Journal: Kidney international 20050401
Title: K/DOQI practice guidelines for bone metabolism and disease in chronic kidney disease: another opportunity for renal dietitians to take a leadership role in improving outcomes for patients with chronic kidney disease.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20050401
Title: Predictive factors of low HCO3- levels in peritoneal dialysis patients.
Journal: Clinical nephrology 20050401
Title: Vascular calcifications in chronic kidney disease: are there new treatments?
Journal: Current vascular pharmacology 20050401
Title: The therapeutic potential of novel phosphate binders.
Journal: Pediatric nephrology (Berlin, Germany) 20050301
Title: Sevelamer and pharmacokinetics of cyclosporin A after kidney transplantation.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050301
Title: Drug interaction between sevelamer and cyclosporin.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050301
Title: Sevelamer-induced acidosis.
Journal: Kidney international 20050201
Title: Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050201
Title: The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050201
Title: Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050201
Title: Different routes bridging calcium in Japanese hemodialysis patients.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050201
Title: Hyperphosphatemia in renal failure.
Journal: Blood purification 20050101
Title: [Sevelamer:hydrochloride].
Journal: Clinical calcium 20050101
Title: Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.
Journal: Arthritis and rheumatism 20050101
Title: Phosphorus management in end-stage renal disease.
Journal: Seminars in dialysis 20050101
Title: [Control of calcium and phosphate metabolism and prevention of vascular calcifications in uremic patients].
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20050101
Title: Plasma aluminium: a redundant test for patients on dialysis?
Journal: Annals of clinical biochemistry 20050101
Title: Metabolic acidosis aggravation and hyperkaliemia in hemodialysis patients treated by sevelamer hydrochloride.
Journal: Renal failure 20050101
Title: Cardiovascular calcification progression -- a comparison of sevelamer and calcium-based phosphate binders.
Journal: Blood purification 20050101
Title: The clinical management of hyperphosphatemia.
Journal: Journal of nephrology 20050101
Title: [New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20050101
Title: Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients.
Journal: Renal failure 20050101
Title: Effects of efficient phosphate binding on bone in chronic renal failure rats.
Journal: Renal failure 20050101
Title: A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients.
Journal: Nephron. Clinical practice 20050101
Title: Increase in serum magnesium level in haemodialysis patients receiving sevelamer hydrochloride.
Journal: International urology and nephrology 20050101
Title: Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20050101
Title: Peritoneal dialysis patients using sevelamer do not present the acidosis problems that hemodialysis patients do.
Journal: Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 20050101
Title: Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value.
Journal: Core evidence 20050101
Title: Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders.
Journal: Nephrology (Carlton, Vic.) 20041201
Title: The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20041001
Title: Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease?
Journal: Kidney international 20041001
Title: [New aspects in the management of renal osteodystrophy].
Journal: Polskie Archiwum Medycyny Wewnetrznej 20041001
Title: Pathophysiology of vascular calcification in chronic kidney disease.
Journal: Circulation research 20040917
Title: Cardiovascular calcification in patients with chronic renal failure: are we on target with this risk factor?
Journal: Kidney international. Supplement 20040901
Title: Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications.
Journal: Kidney international. Supplement 20040901
Title: A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States.
Journal: Kidney international 20040901
Title: Arterial calcification in chronic kidney disease.
Journal: Seminars in nephrology 20040901
Title: Management of calcium and bone abnormalities in hemodialysis patients.
Journal: Seminars in nephrology 20040901
Title: [Prophylaxis and treatment of adynamic bone].
Journal: Clinical calcium 20040901
Title: [Evolution in vitamin D treatment after debut of sevelamer hydrochloride in chronic renal failure patients].
Journal: Clinical calcium 20040901
Title: Phosphate binders in dialyzed patients: efficacy and cost.
Journal: Pediatric nephrology (Berlin, Germany) 20040801
Title: Vascular calcification in patients with end-stage renal disease.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040801
Title: Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification.
Journal: Clinical nephrology 20040801
Title: Dietary phosphorus reduction by pretreatment of human breast milk with sevelamer.
Journal: Pediatric nephrology (Berlin, Germany) 20040701
Title: Drug interaction between sevelamer and cyclosporin.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040701
Title: The role of sevelamer in achieving the kidney disease outcomes quality initiative (K/DOQI) guidelines for hyperphosphatemia.
Journal: Current medical research and opinion 20040701
Title: Determination of the binding parameter constants of Renagel capsules and tablets at pH 7 by high performance capillary electrophoresis.
Journal: Journal of pharmaceutical and biomedical analysis 20040629
Title: Determinants of progressive vascular calcification in haemodialysis patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040601
Title: Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients.
Journal: Saudi medical journal 20040601
Title: [Treatment for chronic kidney failure with cerebrovascular disease].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040601
Title: [Ischemic heart disease].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040601
Title: [Evaluation of coronary artery calcification in ESRD patients].
Journal: Clinical calcium 20040601
Title: [Sevelamer hydrochloride prevents ectopic calcification of blood vessels].
Journal: Clinical calcium 20040601
Title: Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).
Journal: Kidney international 20040501
Title: [Phosphate binding therapy].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040501
Title: [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
Journal: Clinical calcium 20040501
Title: [Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Journal: Clinical calcium 20040501
Title: [Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
Journal: Clinical calcium 20040501
Title: [Mechanism and therapy of vascular calcification].
Journal: Clinical calcium 20040501
Title: [Front line of management of hyperphosphatemia in hemodialysis patients].
Journal: Clinical calcium 20040501
Title: Nephrogenic fibrosing dermopathy in pediatric patients.
Journal: Pediatric nephrology (Berlin, Germany) 20040401
Title: Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20040301
Title: Improving phosphate-binder therapy as a way forward.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040301
Title: Drug interaction between sevelamer and cyclosporin.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040201
Title: [Skeletal complications of renal insufficiency].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040201
Title: An unusual case of calciphylaxis.
Journal: Journal of cutaneous medicine and surgery 20040101
Title: Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Journal: The Journal of heart valve disease 20040101
Title: Management of hyperphosphataemia in dialysis patients: role of phosphate binders in the elderly.
Journal: Drugs & aging 20040101
Title: Safety and efficacy of sevelamer in the treatment of uncontrolled hyperphosphataemia of haemodialysis patients.
Journal: Nephron. Clinical practice 20040101
Title: [Treatment of hyperphosphatemia with sevelamer in patients with chronic renal failure].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101
Title: [Disturbances of mineral metabolism and vascular calcifications in dialysis patients (review)].
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20040101
Title: [The treatment of osteodystrophy in dialyzed uremic patients: results of the first Sardinian audit].
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20040101
Title: BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Journal: BMC nephrology 20040101
Title: Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure.
Journal: Seminars in dialysis 20040101
Title: Sevelamer hydrochloride: an effective phosphate binder in dialyzed children.
Journal: Pediatric nephrology (Berlin, Germany) 20031201
Title: Sevelamer: where are the data?
Journal: Kidney international 20031201
Title: Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20031201
Title: Construction of a cis-cyclopropane via reductive radical decarboxylation. Enantioselective synthesis of cis- and trans-1-arylpiperazyl-2-phenylcyclopropanes designed as antidopaminergic agents.
Journal: The Journal of organic chemistry 20031128
Title: Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Journal: Kidney international 20031101
Title: [Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20031101
Title: Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20031001
Title: Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20031001
Title: Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function.
Journal: Journal of the American Society of Nephrology : JASN 20030901
Title: Slowing the progression of vascular calcification in hemodialysis.
Journal: Journal of the American Society of Nephrology : JASN 20030901
Title: Impact of dyslipidemia in end-stage renal disease.
Journal: Journal of the American Society of Nephrology : JASN 20030901
Title: Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.
Journal: Kidney international 20030801
Title: Affinity labeling of a single guanine bulge.
Journal: Journal of the American Chemical Society 20030730
Title: Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
Journal: Current opinion in nephrology and hypertension 20030701
Title: Prevention and treatment of secondary hyperparathyroidism: still a challenge for the nephrologist?
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030701
Title: Hyperphosphataemia and treatment with sevelamer in haemodialysis patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030701
Title: Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate.
Journal: Kidney international. Supplement 20030601
Title: Medical management of secondary hyperparathyroidism in chronic renal failure.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030601
Title: Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030601
Title: Phosphate binder usage in kidney failure patients.
Journal: Expert opinion on pharmacotherapy 20030601
Title: A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies.
Journal: Clinical nephrology 20030601
Title: Management of hyperphosphataemia in chronic renal disease: lessons from the past and future directions.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030401
Title: The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20030401
Title: Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients.
Journal: Advances in renal replacement therapy 20030401
Title: Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030301
Title: New strategies for the treatment of secondary hyperparathyroidism.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20030301
Title: Calcium on trial: beyond a reasonable doubt?
Journal: Kidney international 20030101
Title: Calcium on trial: beyond a reasonable doubt?
Journal: Kidney international 20030101
Title: Hyperphosphataemia in renal failure: causes, consequences and current management.
Journal: Drugs 20030101
Title: [Critical appraisal of sevelamer for the treatment of hyperphosphatemia in patients with chronic renal failure].
Journal: Revista da Associacao Medica Brasileira (1992) 20030101
Title: Vascular calcification in chronic renal failure.
Journal: Nephron. Clinical practice 20030101
Title: [Management of hyperphosphoremia].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20030101
Title: Sevelamer.
Journal: Nephron. Clinical practice 20030101
Title: The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.
Journal: American journal of nephrology 20030101
Title: Safety of new phosphate binders for chronic renal failure.
Journal: Drug safety 20030101
Title: [Experience with sevelamer in peritoneal dialysis].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20030101
Title: [Renal osteodystrophy Guidelines].
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20030101
Title: Medication-related problem type and appearance rate in ambulatory hemodialysis patients.
Journal: BMC nephrology 20030101
Title: Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Journal: Journal of nephrology 20030101
Title: Oral calcium, sevelamer and vascular calcification in uraemic patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20021201
Title: Pathophysiology and recent advances in the management of renal osteodystrophy.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20021201
Title: Recent advances in nephrology: highlights from the 35th annual meeting of the American society of nephrology.
Journal: Drugs of today (Barcelona, Spain : 1998) 20021201
Title: Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients.
Journal: Nephron 20021001
Title: Effect of phosphate binders on supplemental iron absorption in healthy subjects.
Journal: Journal of clinical pharmacology 20021001
Title: The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
Journal: Journal of the American Society of Nephrology : JASN 20020901
Title: A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020901
Title: Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care.
Journal: Clinical nephrology 20020901
Title: Bile acid binding to sevelamer HCl.
Journal: Kidney international 20020801
Title: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
Journal: Kidney international 20020701
Title: Determination of the binding parameter constants of Renagel capsules and tablets utilizing the Langmuir approximation at various pH by ion chromatography.
Journal: Journal of pharmaceutical and biomedical analysis 20020620
Title: The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020201
Title: Revision of absolute configuration of enantiomeric (methylenecyclopropyl)carbinols obtained from (R)-(-)- and (S)-(+)-epichlorohydrin and methylenetriphenylphosphorane. Implications for reaction mechanism and improved synthesis of antiviral methylenecyclopropane analogues of nucleosides.
Journal: The Journal of organic chemistry 20020111
Title: Phosphate binders in uraemia: pharmacodynamics, pharmacoeconomics, pharmacoethics.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101
Title: Sevelamer, a phosphate-binding polymer, is a non-absorbed compound.
Journal: Clinical pharmacokinetics 20020101
Title: RenaGel efficacy in severe secondary hyperparathyroidism.
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20020101
Title: Treatment with sevelamer decreases bicarbonate levels in peritoneal dialysis patients.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20020101
Title: Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel), a noncalcemic phosphate binder.
Journal: Nephron 20011101
Title: New approaches to the treatment of calcium and phosphorus abnormalities in patients on hemodialysis.
Journal: Current opinion in nephrology and hypertension 20011101
Title: [Control of the secondary hyperparathyroidism by the suppression of plasma phosphate level in chronic renal failure patients].
Journal: Clinical calcium 20011001
Title: Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010901
Title: Sevelamer, Ca x P product and vitamin D.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010201
Title: Sevelamer hydrochloride (Renagel), a nonabsorbed phosphate-binding polymer, does not interfere with digoxin or warfarin pharmacokinetics.
Journal: Journal of clinical pharmacology 20010201
Title: Sevelamer hydrochloride (Renagel), a phosphate-binding polymer, does not alter the pharmacokinetics of two commonly used antihypertensives in healthy volunteers.
Journal: Journal of clinical pharmacology 20010201
Title: Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients.
Journal: Journal of nephrology 20010101
